Cataract Clinical Trial
Official title:
Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Laser Refractive Surgery
This is a single-center, randomized, open, positive product, parallel controlled trial to
evaluate the clinical outcomes of presbyopia-correcting intraocular lenses(IOLs) in eyes with
previous corneal refractive surgery.
Specific Aim 1 (Primary): To compare the surgical successful rate of Multifocal and Extended
Depth-of-Focus IOLs with Monofocal IOLs for the treatment in eyes with previous corneal
refractive surgery.
Specific Aim 2 (Secondary): To study the suboptimal surgical outcomes between Multifocal and
Extended Depth-of-Focus IOLs with Monofocal IOLs for the treatment in eyes with previous
corneal refractive surgery.
Recently, the demands for myopia correction and corneal refractive laser surgery are rising
with the increased prevalence of myopia. Corneal laser refractive surgery includes
photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK),
laser-assisted subepithelial keratomileusis ( LASEK), femtosecond assisted laser in situ
keratomileusis (FS-LASIK), and small incision lenticule extraction(SMILE). At present,
FS-LASIK and SMILE are the mainstream methods for correcting myopia refractive surgery with
advantages of safety, reliability, predictability and stability compared with other types of
refractive surgery. Cataract is the most important cause of blindness in my country and even
in the world. More than 50% of blind people are caused by cataract. Many patients who have
undergone corneal laser refractive surgery may develop presbyopia or cataracts with age.
Phacoemulsification and intraocular lens(IOLs) implantation are the main methods for cataract
due to lacking effective pharmaceutical treatments. In addition, the patients who use
traditional monofocal IOLs without the ability of accommodation may fail to get rid of
glasses. Therefore, a solution that can provide both distance vision and near vision is
needed to the presbyopia or cataracts patients with previous corneal refractive surgery and
accustomed to taking glasses off.The application of presbyopic IOL in cataract after corneal
refractive surgery become extensive with the IOL technology continuously advancing, including
Extended Depth-of-Focus(EDOF) IOL, multifocal IOL(especially trifocal IOL) and so on, which
can improve the distance, middle, and near visual acuity conducing to reduce the rate of
wearing glasses after cataract surgery.
This project is a single-center, randomized, open, positive product, parallel controlled
trial to study the clinical outcomes and applied value of presbyopic IOLs, including EDOF and
trifocal IOLs after corneal laser refractive surgery complicated with cataracts, and seek
better solutions to enable patients to achieve satisfactory visual quality and refractive
results after surgery, culminating in completing patients' demand of taking glasses off.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |